Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 19Breast Neoplasms 15Prostatic Neoplasms 14Colorectal Neoplasms 14Hematopoietic and Lymphatic System Neoplasm 12Lung Neoplasms 10Ovarian Neoplasms 5Multiple Myeloma 5Hematologic Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Malignant Solid Neoplasm 4Hematopoietic and Lymphoid System Neoplasm 4Depression 4Uterine Cervical Neoplasms 3Neoplasm Metastasis 3Lymphoma 3Laryngeal Neoplasms 3Head and Neck Neoplasms 3Anxiety Disorders 3Anatomic Stage I Breast Cancer AJCC v8 3Advanced Malignant Solid Neoplasm 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Thyroid Cancer, Papillary 2Oropharyngeal Neoplasms 2Mouth Neoplasms 2Motor Activity 2Melanoma 2Malignant Female Reproductive System Neoplasm 2Leukemia 2

Interventions

Standard of Care 1Interviews as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × ACT-GEN × Interviews as Topic × Clear all
NCT07565467 2026-05-04

ACT-GEN (Adherence And Care Tracking In GENetic Cancer Syndromes)

M.D. Anderson Cancer Center

Phase NA Not yet recruiting
80 enrolled

ACT-GEN

Data powered by HemOnc (CC BY 4.0) Colophon âš¡